Clinical and Translational Radiation Oncology

Article	Citations
COVID-19: Global radiation oncology’s targeted response for pandemic preparedness	144
4D-MRI driven MR-guided online adaptive radiotherapy for abdominal stereotactic body radiation therapy on a high field MR-Linac: Implementation and initial clinical experience	64
The tumor microenvironment and radiotherapy response; a central role for cancer-associated fibroblasts	61
Daily adaptive radiotherapy for patients with prostate cancer using a high field MR-linac: Initial clinical experiences and assessment of delivered doses compared to a C-arm linac	50
Low dose lung radiotherapy for COVID-19 pneumonia. The rationale for a cost-effective anti-inflammatory treatment	47
A review of the role of MRI in diagnosis and treatment of early stage lung cancer	34
The technical design and concept of a PET/CT linac for biology-guided radiotherapy	33
Evaluation of daily online contour adaptation by radiation therapists for prostate cancer treatment on an MRI-guided linear accelerator	27
Marker-less online MR-guided stereotactic body radiotherapy of liver metastases at a 1.5 T MR-Linac – Feasibility, workflow data and patient acceptance	27
Influence of dose-averaged linear energy transfer on tumour control after carbon-ion radiation therapy for pancreatic cancer	25
Omission of postoperative radiation after breast conserving surgery: A progressive paradigm shift towards precision medicine	24
Evaluation of deep learning-based multiparametric MRI oropharyngeal primary tumor auto-segmentation and investigation of input channel effects: Results from a prospective imaging registry	23
Whole Brain Irradiation or Stereotactic RadioSurgery for five or more brain metastases (WHOBI-STER): A prospective comparative study of neurocognitive outcomes, level of autonomy in daily activities a	22
Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancer	21
Stability analysis of CT radiomic features with respect to segmentation variation in oropharyngeal cancer	20
CDK 4/6 inhibitors combined with radiotherapy: A review of literature	20
Radiomic biomarkers of tumor immune biology and immunotherapy response	20
Incidence and dose-volume relationship of radiation pneumonitis after concurrent chemoradiotherapy followed by durvalumab for locally advanced non-small cell lung cancer	18
Dose-dependent volume loss in subcortical deep grey matter structures after cranial radiotherapy	18
Long-term results of multimodal peptide receptor radionuclide therapy and fractionated external beam radiotherapy for treatment of advanced symptomatic meningioma	17
NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience	17
PIVOTALboost: A phase III randomised controlled trial of prostate and pelvis versus prostate alone radiotherapy with or without prostate boost (CRUK/16/018)	16
The changing role of radiation oncology professionals in a world of AI – Just jobs lost – Or a solution to the under-provision of radiotherapy?	15
Evaluation of erectile potency and radiation dose to the penile bulb using image guided radiotherapy in the CHHiP trial	15
Scalp angiosarcoma treated with linear accelerator-based boron neutron capture therapy: A report of two patients	15

RADIANCE – Radiochemotherapy with or without Durvalumab in the treatment of anal squamous cell carcinoma: A randomized multicenter phase II trial	15
Ultrasound delta-radiomics during radiotherapy to predict recurrence in patients with head and neck squamous cell carcinoma	14
CONCORDE: A phase I platform study of novel agents in combination with conventional radiotherapy in non-small-cell lung cancer	14
Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patients	14
Low dose anti-inflammatory radiotherapy for the treatment of pneumonia by covid-19: A proposal for a multi-centric prospective trial	14
Metastases-directed Radiotherapy in Addition to Standard Systemic Therapy in Patients with Oligometastatic Breast Cancer: Study protocol for a randomized controlled multi-national and multi-center cli	13
Efficacy and toxicity outcomes for patients treated with focal salvage high dose rate brachytherapy for locally recurrent prostate cancer	13
Selection criteria for early breast cancer patients in the DBCG proton trial – The randomised phase III trial strategy	13
Auto-segmentations by convolutional neural network in cervical and anorectal cancer with clinical structure sets as the ground truth	13
X-rays minibeam radiation therapy at a conventional irradiator: Pilot evaluation in F98-glioma bearing rats and dose calculations in a human phantom	13
Radiotherapy-related lymphopenia in patients with advanced non-small cell lung cancer receiving palliative radiotherapy	13
ESTRO/ACROP IORT recommendations for intraoperative radiation therapy in locally recurrent rectal cancer	12
PSMA-11-PET/CT versus choline-PET/CT to guide stereotactic ablative radiotherapy for androgen deprivation therapy deferral in patients with oligometastatic prostate cancer	12
MR-guided stereotactic body radiation therapy for intracardiac and pericardial metastases	11
Feasibility of MR-guided ultrahypofractionated radiotherapy in 5, 2 or 1 fractions for prostate cancer	11
1.5 T MR-linac planning study to compare two different strategies of rectal boost irradiation	11
Conducting research in Radiation Oncology remotely during the COVID-19 pandemic: Coping with isolation	11
ESTRO/ACROP IORT recommendations for intraoperative radiation therapy in primary locally advanced rectal cancer	11
Blood-brain barrier permeability following conventional photon radiotherapy – A systematic review and meta-analysis of clinical and preclinical studies	11
European radiation oncology after one year of COVID-19 pandemic	11
GEC ESTRO ACROP consensus recommendations for contact brachytherapy for rectal cancer	11
Phase I study of the PARP inhibitor talazoparib with radiation therapy for locally recurrent gynecologic cancers	11
The impact of immunotherapy on the survival of pancreatic adenocarcinoma patients who do not receive definitive surgery of the tumor	10
Estimated clinical benefit of combining highly conformal target volumes with Volumetric-Modulated Arc Therapy (VMAT) versus conventional flank irradiation in pediatric renal tumors	10
Stereotactic radiotherapy with focal boost for intermediate and high-risk prostate cancer: Initial results of the SPARC trial	10
The impact of tongue-deviating and tongue-depressing oral stents on long-term radiation-associated symptoms in oropharyngeal cancer survivors	10
DCE-MRI assessment of response to neoadjuvant SABR in early stage breast cancer: Comparisons of single versus three fraction schemes and two different imaging time delays post-SABR	10
Late toxicity in the brain after radiotherapy for sinonasal cancer: Neurocognitive functioning, MRI of the brain and quality of life	10
Mesorectal radiotherapy for early stage rectal cancer: A novel target volume	10
Nitroglycerin as a radiosensitizer in non-small cell lung cancer: Results of a prospective imaging-based phase II trial	10
Decreased heart dose with deep inspiration breath hold for the treatment of gastric lymphoma with IMRT	10
Do radiation oncologists talk about sexual health and dysfunction with their cancer patients? Results of the igls-vienna-sexmed-survey	9
ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy in borderline-resected pancreatic cancer	9
[18F]-HX4 PET/CT hypoxia in patients with squamous cell carcinoma of the head and neck treated with chemoradiotherapy: Prognostic results from two prospective trials	9
Dose constraints for whole breast radiation therapy based on the quality assessment of treatment plans in the randomised Danish breast cancer group (DBCG) HYPO trial	9
Development and results of a patient-reported treatment experience questionnaire on a 1.5 T MR-Linac	9
Patient-reported quality of life and toxicity in unilateral and bilateral radiotherapy for early-stage human papillomavirus associated tonsillar carcinoma	9
Clinical outcomes and toxicity predictors of thoracic re-irradiation for locoregionally recurrent lung cancer	9
Replacing 30 Gy in 10 fractions with stereotactic body radiation therapy for bone metastases: A large multi-site single institution experience 2016–2018	8
High-dose rate brachytherapy in localized penile cancer: 5-Year clinical outcome analysis	8
Cardiac radioablation in the treatment of ventricular tachycardia	8
Bladder preserving chemoradiotherapy compared to surgery for variants of urothelial carcinoma and other tumors types involving the bladder: An analysis of the National Cancer Database	8
Recurrence of head and neck squamous cell carcinoma in relation to high-risk treatment volume	8
Prediction models for treatment-induced cardiac toxicity in patients with non-small-cell lung cancer: A systematic review and meta-analysis	8
Definition and validation of a radiomics signature for loco-regional tumour control in patients with locally advanced head and neck squamous cell carcinoma	8
Concurrent paclitaxel and radiation therapy for the treatment of cutaneous angiosarcoma	8
Analysis of the electron-stream effect in patients treated with partial breast irradiation using the 1.5 T MR-linear accelerator	8
Sex-related differences in primary metastatic site in rectal cancer; associated with hemodynamic factors?	8
Machine learning highlights the deficiency of conventional dosimetric constraints for prevention of high-grade radiation esophagitis in non-small cell lung cancer treated with chemoradiation	8
Abscopal effect in a patient with malignant pleural mesothelioma treated with palliative radiotherapy and pembrolizumab	8

Breast cancer radiation therapy: A bibliometric analysis of the scientific literature	7
Correlation of normal lung density changes with dose after stereotactic body radiotherapy (SBRT) for early stage lung cancer	7
Prophylactic cranial irradiation in patients with small cell lung cancer in The Netherlands: A population-based study	7
Combining radiotherapy and focused ultrasound for pain palliation of cancer induced bone pain; a stage I/IIa study according to the IDEAL framework	7
Hypoxia in relationship to tumor volume using hypoxia PET-imaging in head & neck cancer – A scoping review	7
The addition of deep hyperthermia to gemcitabine-based chemoradiation may achieve enhanced survival in unresectable locally advanced adenocarcinoma of the pancreas	7
Prospective study of artificial intelligence-based decision support to improve head and neck radiotherapy plan quality	7
Immunotherapy with or without radiotherapy for metastatic or recurrent esophageal squamous cell carcinoma: A real-world study	7
Longitudinal characterization of the tumoral microbiome during radiotherapy in HPV-associated oropharynx cancer	7
Efficacy and feasibility of re-irradiation using carbon ions for pancreatic cancer that recurs after carbon-ion radiotherapy	7
Auto-detection and segmentation of involved lymph nodes in HPV-associated oropharyngeal cancer using a convolutional deep learning neural network	7
The potential role of MR-guided adaptive radiotherapy in pediatric oncology: Results from a SIOPE-COG survey	7
A radiomics-based model for predicting local control of resected brain metastases receiving adjuvant SRS	7
Quality-of-life and toxicity in cancer patients treated with multiple courses of radiation therapy	6
Lattice Radiation Therapy in clinical practice: A systematic review	6
Dacomitinib and gedatolisib in combination with fractionated radiation in head and neck cancer	6
Limited-stage small cell lung cancer: Outcomes associated with prophylactic cranial irradiation over a 20-year period at the Princess Margaret Cancer Centre	6
The role of dietary supplements, including biotics, glutamine, polyunsaturated fatty acids and polyphenols, in reducing gastrointestinal side effects in patients undergoing pelvic radiotherapy: A syst	6
High-dose-rate brachytherapy boost for locally advanced cervical cancer: Oncological outcome and toxicity analysis of 4 fractionation schemes	6
De-intensification for HPV positive oropharyngeal cancer: and yet it moves!	6
Defining radio-recurrent intra-prostatic target volumes using PSMA-targeted PET/CT and multi-parametric MRI	6
In-vivo and in-vitro impact of high-dose rate radiotherapy using flattening-filter-free beams on the anti-tumor immune response	6
Radiation dermatitis in patients treated with concurrent trastuzumab emtansine (T-DM1)	6
The effect of pelvic radiation alone on lymphocyte subgroups	6
A scoping review of small animal image-guided radiotherapy research: Advances, impact and future opportunities in translational radiobiology	6
High-dose re-irradiation of intracranial lesions – Efficacy and safety including dosimetric analysis based on accumulated EQD2Gy dose calculation	6
Online adaptive radiotherapy for head and neck cancers on the MR linear Accelerator: Introducing a novel modified Adapt-to-Shape approach	6
The individual risk of symptomatic radionecrosis after brain metastasis radiosurgery is predicted by a continuous function of the V12Gy	6
PROMIS scores of patients undergoing neoadjuvant and adjuvant radiation therapy for surgically excised soft tissue sarcoma	6
Inter-clinician delineation variation for a new highly-conformal flank target volume in children with renal tumors: A SIOP-Renal Tumor Study Group international multicenter exercise	6
Predictive and prognostic value of inflammatory markers in locally advanced rectal cancer (PILLAR) – A multicentric analysis by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Gas	5
Prognosis of severe lymphopenia after postoperative radiotherapy in non-small cell lung cancer: Results of a long-term follow up study	5
TORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer	5
Cetuximab, gemcitabine and radiotherapy in locally advanced pancreatic cancer: Long-term results of the randomized controlled phase II PARC trial	5
Nodal recurrence patterns on PET/CT after RTOG-based nodal radiotherapy for prostate cancer	5
The role of large volume re-irradiation with Bevacizumab in chemorefractory high grade glioma	5
Long-term patient-reported distress in locally advanced cervical cancer patients treated with definitive chemoradiation	5
Phase I/II trial of concurrent extracranial palliative radiation therapy with Dabrafenib and Trametinib in metastatic BRAF V600E/K mutation-positive cutaneous Melanoma	5
Risk factor of pneumonitis on dose-volume relationship for chemoradiotherapy with durvalumab: Multi-institutional research in Japan	5
Using the revised Edmonton symptom assessment scale during neoadjuvant radiotherapy for retroperitoneal sarcoma	5
Air variability in maxillary sinus during radiotherapy for sinonasal carcinoma	5
Curative management of a cardiac metastasis from lung cancer revealed by an electrical storm	5
Prolonging deep inspiration breath-hold time to 3 min during radiotherapy, a simple solution	5
Re-irradiation for oligoprogression under Nivolumab in recurrent head and neck squamous cell carcinoma: A case report	5
Voluntary versus ABC breath-hold in the context of VMAT for breast and locoregional lymph node radiotherapy including the internal mammary chain	5
A prospective behavioral and imaging study exploring the impact on long-term memory of radiotherapy delivered for a brain tumor in childhood and adolescence	5
Outcome and toxicity of hypofractionated image-guided SABR for spinal oligometastases	5
Patient reported outcomes following proton pencil beam scanning vs. passive scatter/uniform scanning for localized prostate cancer: Secondary analysis of PCG 001-09	5
Dosimetric and volumetric outcomes of combining cyst puncture through an Ommaya reservoir with index-optimized hypofractionated stereotactic radiotherapy in the treatment of craniopharyngioma	5
PD-L1 induction in tumor tissue after hypofractionated thoracic radiotherapy for non-small cell lung cancer	5
Impact of transitioning to an online course – A report from the ESTRO gyn teaching course	5
Clinical response assessment after contact X-Ray brachytherapy and chemoradiotherapy for organ preservation in rectal cancer T2-T3 M0: The time/dose factor influence	5
Morphological changes after cranial fractionated photon radiotherapy: Localized loss of white matter and grey matter volume with increasing dose	5
Clinical implementation and feasibility of long-course fractionated MR-guided chemoradiotherapy for patients with esophageal cancer: An R-IDEAL stage 1b/2a evaluation of technical innovation	5
ACO/ARO/AIO-21 - Capecitabine-based chemoradiotherapy in combination with the IL-1 receptor antagonist anakinra for rectal cancer Patients: A phase I trial of the German rectal cancer study group	5
A practical approach to bladder preservation with hypofractionated radiotherapy for localised muscle-invasive bladder cancer	5
Prospective observational evaluation of radiation-induced late taste impairment kinetics in oropharyngeal cancer patients: Potential for improvement over time?	5
Preoperative robotic radiosurgery for early breast cancer: Results of the phase II ROCK trial (NCT03520894)	5
Large anatomical changes in head-and-neck cancers – A dosimetric comparison of online and offline adaptive proton therapy	5
Patient reported toxicity and quality of life after hypofractionated high-dose intensity-modulated radiotherapy for intermediate- and high risk prostate cancer	4
Temporal lobe microstructural abnormalities in patients with nasopharyngeal carcinoma quantitatively evaluated by high-resolution DWI and DKI after concurrent chemoradiotherapy	4
Proton therapy of a pregnant patient with nasopharyngeal carcinoma	4
Intensity modulated radiotherapy for anal canal squamous cell carcinoma: A 16-year single institution experience	4
Adaptive radiotherapy for breast cancer	4
Margin negative resection and pathologic downstaging with multiagent chemotherapy with or without radiotherapy in patients with localized pancreas cancer: A national cancer database analysis	4
Radiotherapy for elder patients aged ≥80 with clinically localized prostate cancer – Brachytherapy enhanced late GU toxicity especially in elderly	4
Cleaning radiotherapy contours for radiomics studies, is it worth it? A head and neck cancer study	4
Oxygen-enhanced MRI MOLLI T1 mapping during chemoradiotherapy in anal squamous cell carcinoma	4
Endocrine therapy with accelerated Partial breast irradiatiOn or exclusive ultra-accelerated Partial breast irradiation for women aged ≥ 60 years with Early-stage breast cancer (EPOPE): The rationale	4
Reproducibility of Deep-Inspiration Breath Hold treatments on Halcyon™ performed using the first clinical version of AlignRT InBore™: Results of CYBORE study	4
Delineation uncertainties of tumour volumes on MRI of head and neck cancer patients	4
The ALERT-B questionnaire: A screening tool for the detection of gastroenterological late effects after radiotherapy for prostate cancer	4
Implementing cone-beam computed tomography-guided online adaptive radiotherapy in cervical cancer	4
Is prostate cancer radiotherapy using implantable rectum spacers safe and effective in inflammatory bowel disease patients?	4
Long-term volumetric analysis of vestibular schwannomas following stereotactic radiotherapy: Practical implications for follow-up	4
Enhancing radiation response by a second-generation TRAIL receptor agonist using a new in vitro organoid model system	4
Re-irradiation with concurrent and maintenance nivolumab in locally recurrent and inoperable squamous cell carcinoma of the head and neck: A single-center cohort study	4
A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemic	4
Treatment of oligometastatic lung cancer with brain metastases using stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT)	4
Could the conservative approach be considered safe in the treatment of locally advanced rectal cancer in case of a clinical near-complete or complete response? A retrospective analysis	4

Phase I trial of the MEK inhibitor selumetinib in combination with thoracic radiotherapy in non-small cell lung cancer	4
Interrater agreement of contouring of the neurovascular bundles and internal pudendal arteries in neurovascular-sparing magnetic resonance-guided radiotherapy for localized prostate cancer	4
Determining the safety of ultrafocal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer: A toxicity assessment of 150 patients	4
The timing and design of stereotactic radiotherapy approaches as a part of neoadjuvant therapy in pancreatic cancer: Is it time for change?	4
Evaluating single-institution resource costs of consolidative radiotherapy for oligometastatic non-small cell lung cancer using time-driven activity-based costing	4
Prognostic utility of pretreatment neutrophil-lymphocyte ratio in survival outcomes in localized non-small cell lung cancer patients treated with stereotactic body radiotherapy: Selection of an ideal	4
Dose-volume predictors of post-radiation primary hypothyroidism in head and neck cancer: A systematic review	4
Adoption of single fraction radiotherapy for uncomplicated bone metastases in a tertiary centre	4
Time- and dose-dependent volume decreases in subcortical grey matter structures of glioma patients after radio(chemo)therapy	4
Management of initial and recurrent radiation-induced contrast enhancements following radiotherapy for brain metastases: Clinical and radiological impact of bevacizumab and corticosteroids	3
Pseudo-siamese network combined with dosimetric and clinical factors, radiomics features, CT images and 3D dose distribution for the prediction of radiation pneumonitis: A feasibility study	3
Magnetic resonance imaging-derived radiomic signature predicts locoregional failure after organ preservation therapy in patients with hypopharyngeal squamous cell carcinoma	3
The safety and efficacy of a novel hypo-fractionated total marrow and lymphoid irradiation before allogeneic stem cell transplantation for lymphoma and acute leukemia	3
Stereotactic magnetic resonance-guided online adaptive radiotherapy of adrenal metastases combines high ablative doses with optimized sparing of organs at risk	3
A pilot study of same-day MRI-only simulation and treatment with MR-guided adaptive palliative radiotherapy (MAP-RT)	3
Redefining postmastectomy radiation contouring in the era of immediate breast reconstruction: An accurate assessment of local recurrence risk	3
Comparison of intratumor and local immune response between MV X-ray FLASH and conventional radiotherapies	3
Experts consensus on epidemic prevention and control in radiotherapy centers during the COVID-19 outbreak: Experiences from Sichuan Province	3
Development and internal validation of multivariable prediction models for biochemical failure after MRI-guided focal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer	3
Radiotherapy for pediatric adrenocortical carcinoma – Review of the literature	3
Impact of suboptimal dosimetric coverage of pretherapeutic 18F-FDG PET/CT hotspots on outcome in patients with locally advanced cervical cancer treated with chemoradiotherapy followed by brachytherapy	3
Optimal timing of radiotherapy in high risk prostate cancer: Do missed days matter?	3
The value of plasma hypoxia markers for predicting imaging-based hypoxia in patients with head-and-neck cancers undergoing definitive chemoradiation	3
Associations between patient-reported outcomes and radiation dose in patients treated with radiation therapy for primary brain tumours	3
A national perspective about the current work situation at modern radiotherapy departments	3
Inhalation anesthesia and shielding devices to allow accurate preclinical irradiation of mice with clinical linac-based systems: Design and dosimetric characteristics	3
Circulating cell-free DNA as predictor of pathological complete response in locally advanced rectal cancer patients undergoing preoperative chemoradiotherapy	3
Particle beam therapy for nasopharyngeal cancer: A systematic review and meta-analysis	3
Extraction parameter optimized radiomics for neoadjuvant chemotherapy response prognosis in advanced nasopharyngeal carcinoma	3
PSA decay during salvage radiotherapy for prostate cancer as a predictor of disease outcome – 5 year follow-up of a prospective observational study	3
The overall survival impact of prophylactic cranial irradiation in limited-stage small-cell lung cancer: A systematic review and meta-analysis	3
Assessing concordance between patient-reported and investigator-reported CTCAE after proton beam therapy for prostate cancer	3
Proton Image-guided Radiation Assignment for Therapeutic Escalation via Selection of locally advanced head and neck cancer patients [PIRATES]: A Phase I safety and feasibility trial of MRI-guided adap	3
Comparing pre-operative versus post-operative single and multi-fraction stereotactic radiotherapy for patients with resectable brain metastases	3
18FDG positron emission tomography mining for metabolic imaging biomarkers of radiation-induced xerostomia in patients with oropharyngeal cancer	3
Treatment outcome after radiochemotherapy in anal cancer patients staged with 18F-FDG-PET-CT	3
Stereotactic radiotherapy or metastasectomy for oligometastatic esophagogastric cancer: A nationwide population-based cohort study	2
In response to Korreman s. et al. Radiation oncologists are, above all, medical doctors	2
MRI-based radiomics to predict neoadjuvant chemoradiotherapy outcomes in locally advanced rectal cancer: A multicenter study	2
Long-term outcomes of an esophagus-preserving chemoradiotherapy strategy for patients with endoscopically unresectable stage I thoracic esophageal squamous cell carcinoma	2
A retrospective review of the long-term outcomes of online adaptive radiation therapy and conventional radiation therapy for muscle invasive bladder cancer	2
Nonoperative versus operative approach according to the response to neoadjuvant chemoradiotherapy for rectal cancer: A prospective cohort study	2
Beyond reirradiation: Efficacy and safety of three or more courses of radiation for head and neck malignancies	2
Impact of pretreatment second look 18FDG-PET/CT on stage and treatment changes in head and neck cancer	2
The dogma of Cetuximab and Radiotherapy in head and neck cancer – A dawn to dusk journey	2
Single-institution analysis of the prevalence, indications and outcomes of end-of-life radiotherapy	2
Reduction of intrafraction pancreas motion using an abdominal corset compatible with proton therapy and MRI	2
Risk factors associated with metastatic site failure in patients with high-risk neuroblastoma	2
Current practices and perspectives on the integration of contrast agents in MRI-guided radiation therapy clinical practice: A worldwide survey	2
Propensity score analysis of radical proctectomy versus organ preservation using contact X-ray brachytherapy for rectal cancer	2
Stereotactic lung reirradiation for local relapse: A case series	2
Analysis of data to Advance Personalised Therapy with MR-Linac (ADAPT-MRL)	2
Salvage radiotherapy for relapsed/refractory non‐Hodgkin lymphoma following CD19 chimeric antigen receptor T-cell (CART) therapy	2
The cost of elective nodal coverage in prostate cancer: Late quality of life outcomes and dosimetric analysis with 0, 45 or 54 Gy to the pelvis	2
Patient reported outcomes for quality of life (QOL) by Expanded Prostate Cancer Index (EPIC) on average 15 years post treatment	2
Adjuvant locoregional radiation therapy in breast cancer patients with pathologic complete response after neoadjuvant chemotherapy: A systematic review and meta-analysis	2
MRI-only radiotherapy from an economic perspective: Can new techniques in prostate cancer treatment be cost saving?	2
ESTRO ACROP guideline on prostate bed delineation for postoperative radiotherapy in prostate cancer	2
Overall survival nomogram for patients with spinal bone metastases (SBM)	2
Contemporary use and outcomes of radiation and chemotherapy for unresectable pancreatic cancer	2
AI-assisted clinical decision making (CDM) for dose prescription in radiosurgery of brain metastases using three-path three-dimensional CNN	2
Evaluation of short-term gastrointestinal motion and its impact on dosimetric parameters in stereotactic body radiation therapy for pancreatic cancer	2
Exposure of the heart and cardiac valves in women irradiated for breast cancer 1970–2009	2
The effect of low-dose radiation spillage during stereotactic radiosurgery for brain metastases on the development of de novo metastases	2
Total skin electron beam therapy for cutaneous T-cell lymphomas in the Netherlands: A retrospective analysis of treatment outcomes and selection for high or low dose schedule	2
Age, pathology and CA-125 are prognostic factors for survival in patients with brain metastases from gynaecological tumours	2
Multiple sclerosis as differential diagnosis of radionecrosis for post-irradiation brain lesions: A case report	2
PD-1 and PD-L1 expression predict regression and prognosis following neoadjuvant radiochemotherapy of oesophageal adenocarcinoma	2
A year of pandemic for European particle radiotherapy: A survey on behalf of EPTN working group	2
Recognition of and treatment recommendations for oligometastatic disease in multidisciplinary tumor boards	2
Radiomics biopsy signature for predicting survival in patients with spinal bone metastases (SBMs)	2
Influence of eye movement on lens dose and optic nerve target coverage during craniospinal irradiation	2
Oxygen-enhanced MRI and radiotherapy in patients with oropharyngeal squamous cell carcinoma	2
Thyroid volume changes following adjuvant radiation therapy for breast cancer	2
Prophylactic cranial irradiation for extensive-stage small cell lung cancer: Analysis based on active brain MRI surveillance	2
Long-term follow up of a patient with a recurrent desmoid tumor that was successfully treated with proton beam therapy: A case report and literature review	2
Machine learning for dose-volume histogram based clinical decision-making support system in radiation therapy plans for brain tumors	2
The ROCOCO performance scoring system translates dosimetric differences into clinically relevant endpoints: Comparing IMPT to VMAT in an example pilocytic astrocytoma dataset	2
Treatment interruptions affect biochemical failure rates in prostate cancer patients treated with proton beam therapy: Report from the multi-institutional proton collaborative group registry	2
Clinical outcomes of patients with unresectable primary liver cancer treated with MR-guided stereotactic body radiation Therapy: A Six-Year experience	2
A prospective phase II study of prostate-specific antigen-guided salvage radiotherapy and 68Ga-PSMA-PET for biochemical relapse after radical prostatectomy – The PROPER 1 trial	2
Metformin with neoadjuvant chemoradiation to improve pathologic response in rectal cancer: A pilot phase I/II trial	2
Splenic irradiation contributes to grade ≥ 3 lymphopenia after adjuvant chemoradiation for stomach cancer	2
BRIDGE −1 TRIAL: BReak Interval Delayed surgery for Gastrointestinal Extraperitoneal rectal cancer, a multicentric phase III randomized trial	2
Stereotactic radiosurgery (SRS) – A new normal for small cell lung cancer?	2
Dynamic tumor-tracking stereotactic body radiotherapy with real-time monitoring of liver tumors using a gimbal-mounted linac: A multi-institutional phase II study	2
Lung cancer epidermal growth factor receptor mutations and radiotherapy response: A multicentre clinical study	2
Biopsy-derived oral keratinocytes – A model to potentially test for oral mucosa radiation sensitivity	2
Helical tomotherapy for post-mastectomy radiation therapy with or without breast implant: a single institution experience	2
“Radiotherapy for thymic epithelial tumors: What is the optimal dose? A systematic review.”	2
Targeting K-Ras-mediated DNA damage response in radiation oncology: Current status, challenges and future perspectives	2
Are there overlapping clinical features between thoracic radiotherapy side effects and covid-19 pneumonia? Radiation pneumonitis outside the radiation ports: Three case reports	2
Value of 18F-fluorocholine PET/CT in predicting response to radical radiotherapy in patients with localized prostate cancer	2
Inconsistencies in assessment of pain endpoints in radiotherapy for painful tumors: Analysis of original articles in the Green and Red Journals	2
Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States – Understanding the transition to adaptive, ultra-hypofractionated treatments	2